The remedē®System may be covered by one or more of the following U.S. Patents: US8233987, US8244359, US8433412, US9295846, US9468755, US9744349. This page is intended to serve as notice under 35 U.S.C. § 287(a).
1 in 3 people with heart failure have Central Sleep Apnea and stop breathing during the night. Talk to your doctor about the remedē® System clinical study to see if you qualify. Send us an email at email@example.com or read about our clinical study at www.clinicaltrials.gov.